Artia Global Partners’s Eli Lilly LLY Stock Holding History

Artia Global Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-38,220	Closed	-$35.2M	–	54
2026 Q1	$35.2M	Sell	38,220 -12,280	-24%	-$12.4M	7.04%	4
2025 Q4	$54.3M	Buy	50,500 +21,800	+76%	+$20.8M	7.69%	5
2025 Q3	$21.9M	Sell	28,700 -2,000	-7%	-$1.49M	3.47%	9
2025 Q2	$23.9M	Sell	30,700 -64,187	-68%	-$49.9M	5.76%	5
2025 Q1	$78.4M	Buy	+94,887	New	+$79M	19.84%	1
2024 Q4	–	Sell	-92,593	Closed	-$82M	–	48
2024 Q3	$82M	Hold	92,593	–	–	22.36%	2
2024 Q2	$83.8M	Hold	92,593	–	–	16.2%	2
2024 Q1	$72M	Hold	92,593	–	–	14.48%	3
2023 Q4	$54M	Buy	92,593 +66,400	+254%	+$38.8M	15.7%	2
2023 Q3	$14.1M	Buy	26,193 +10,000	+62%	+$5.15M	5.85%	4
2023 Q2	$7.59M	Sell	16,193 -10,735	-40%	-$4.5M	2.62%	15
2023 Q1	$9.25M	Sell	26,928 -77,400	-74%	-$26.1M	3.42%	11
2022 Q4	$38.2M	Buy	+104,328	New	+$37M	14.55%	2

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Artia Global Partners's LLY Position: Q2 2026 in Review

Artia Global Partners sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 38,220 shares — an estimated $35.2M sold.

Artia Global Partners first reported a position in LLY in Q4 2022 and held it in 13 quarters. The position peaked at $83.8M in Q2 2024. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Artia Global Partners reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
Artia Global Partners sold 38,220 Eli Lilly shares in Q2 2026, an estimated $35.2M.
Artia Global Partners first reported a position in Eli Lilly in Q4 2022 and held it in 13 quarters.
Artia Global Partners's Eli Lilly position peaked at $83.8M in Q2 2024.
4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Artia Global Partners's 13F filing for Q2 2026, filed 14 Aug 2026.